Document is current

Article History

Received: 29 October 2024

Accepted: 19 March 2025

First Online: 2 April 2025

Declarations

:

: The study was approved by Unity Health Toronto’s Research Ethics Board. Before enrolment, written informed consent was obtained from all participants or their legal guardians. The study was conducted according to Unity Health Toronto’s ethical standards and the Declaration of Helsinki.

: All participants provided written informed consent for the publication of anonymized data.

: Dr. Justine Itorralba has nothing to disclose. Ms. Koroboshka Brand-Arzamendi has nothing to disclose. Dr. Georges Saab has received payment or honoraria for presentations, lectures, or educational events from EMD-Serono. Dr. Saab has received funding for international conference attendance from EMD-Serono. Dr Saab received support to attend a scientific meeting and advisory board from EMD-Serono and Hoffman-La Roche. Dr. Alexandra Muccilli has received payment or honoraria for lectures, presentations, speakers’ bureaus and other educational initiatives from Biogen-Idec, EMD-Serono and Novartis. Dr. Raphael Schneider received grants from the MS Society of Canada and the J.P. Bickell Foundation. Dr. Schneider has received consulting fees from Biogen-Idec and Novartis. Dr. Schneider has received payment or honoraria for lectures, presentations, speaker’s bureaus, manuscript writing or educational events from Biogen-Idec, Sanofi-Genzyme, and EMD-Serono. Dr. Schneider has participated on advisory boards for Novartis and BMS. Dr. Schneider has received support for attending a scientific meeting from EMD-Serono.